A patient has developed chronic hepatitis after being exposed to ...

[joesmith1212]

A patient has developed chronic hepatitis after being exposed to hepatitis C. The nurse is discussing treatment of this condition. What information should the nurse include?
 
  1. There are some new medications that help keep the HCV virus from reproducing in your system.
  2. There is not much we can do except support your general health.
  3. Most current research supports the use of multidrug therapy.
  4. A new drug called pegylation has been shown to prevent liver damage.
  5. You should advise your family to take the hepatitis C vaccine.

Question 2

A nurse is discussing how drugs are approved with a healthcare provider. Place the stages of approval for therapeutic and biological drugs in the appropriate sequence.
 
  1. NDA submission with review
  2. Preclinical investigation
  3. Clinical investigation
  4. Postmarketing studies

[tkempin]

Answer to Question 1

1,3
Rationale 1: Several new medications have been developed that interfere with HCV virus replication.
Rationale 2: There are several treatment regimens available.
Rationale 3: Most treatment regimens are multidrug.
Rationale 4: Pegylation is a process to extend effectiveness of interferons.
Rationale 5: There is no hepatitis C vaccine.

Global Rationale: Several new medications have been developed that interfere with HCV virus replication. Most treatment regimens are multidrug. There are several treatment regimens available. Pegylation is a process to extend effectiveness of interferons. There is no hepatitis C vaccine.

Answer to Question 2

2, 3, 1, 4

Global Rationale: The correct order of drug review is preclinical investigation, clinical investigation, NDA submission with review, followed by postmarketing studies.

[joesmith1212]

Both answers were spot on, thank you once again

[tkempin]

Great! Please up vote